| # | Title | Journal | Year | Citations |
|---|
| 1 | Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer | Breast Cancer Research | 2010 | 1,748 |
| 2 | Choosing the right cell line for breast cancer research | Breast Cancer Research | 2011 | 1,153 |
| 3 | PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro | Breast Cancer Research | 2009 | 1,131 |
| 4 | Triple-negative breast cancer molecular subtyping and treatment progress | Breast Cancer Research | 2020 | 1,022 |
| 5 | Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy | Breast Cancer Research | 2008 | 902 |
| 6 | CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis | Breast Cancer Research | 2006 | 839 |
| 7 | Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium | Breast Cancer Research | 2000 | 803 |
| 8 | Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures | Breast Cancer Research | 2008 | 765 |
| 9 | The changing global patterns of female breast cancer incidence and mortality | Breast Cancer Research | 2004 | 724 |
| 10 | Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome | Breast Cancer Research | 2004 | 690 |
| 11 | Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts | Breast Cancer Research | 2005 | 659 |
| 12 | Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells | Breast Cancer Research | 2004 | 658 |
| 13 | Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients | Breast Cancer Research | 2009 | 658 |
| 14 | Breast cancer prognostic classification in the molecular era: the role of histological grade | Breast Cancer Research | 2010 | 650 |
| 15 | Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study | Breast Cancer Research | 2011 | 625 |
| 16 | Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression | Breast Cancer Research | 2007 | 584 |
| 17 | Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients | Breast Cancer Research | 2007 | 576 |
| 18 | Tumor-associated stromal cells as key contributors to the tumor microenvironment | Breast Cancer Research | 2016 | 552 |
| 19 | Gene expression profiling of the tumor microenvironment during breast cancer progression | Breast Cancer Research | 2009 | 547 |
| 20 | Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics | Breast Cancer Research | 2008 | 538 |
| 21 | Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas | Breast Cancer Research | 2007 | 509 |
| 22 | Metalloproteinases: role in breast carcinogenesis, invasion and metastasis | Breast Cancer Research | 2000 | 501 |
| 23 | Mammographic density and breast cancer risk: current understanding and future prospects | Breast Cancer Research | 2011 | 485 |
| 24 | The CD44+/CD24-phenotype is enriched in basal-like breast tumors | Breast Cancer Research | 2008 | 464 |
| 25 | Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis | Breast Cancer Research | 2017 | 457 |
| 26 | Plasma exosome microRNAs are indicative of breast cancer | Breast Cancer Research | 2016 | 434 |
| 27 | A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients | Breast Cancer Research | 2006 | 433 |
| 28 | Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI | Breast Cancer Research | 2017 | 408 |
| 29 | Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | 2014 | 407 |
| 30 | ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 | Breast Cancer Research | 2010 | 406 |
| 31 | Liposome-based drug delivery in breast cancer treatment | Breast Cancer Research | 2002 | 392 |
| 32 | Hypoxia and oxidative stress in breast cancer Oxidative stress - its effects on the growth, metastatic potential and response to therapy of breast cancer | Breast Cancer Research | 2001 | 391 |
| 33 | Quantitative shear wave ultrasound elastography: initial experience in solid breast masses | Breast Cancer Research | 2010 | 389 |
| 34 | T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers | Breast Cancer Research | 2009 | 380 |
| 35 | MicroRNAs and their target gene networks in breast cancer | Breast Cancer Research | 2010 | 380 |
| 36 | Cancer stem cell metabolism | Breast Cancer Research | 2016 | 377 |
| 37 | CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer | Breast Cancer Research | 2012 | 376 |
| 38 | Mammary stem cells, self-renewal pathways, and carcinogenesis | Breast Cancer Research | 2005 | 375 |
| 39 | MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer | Breast Cancer Research | 2009 | 375 |
| 40 | Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer | Breast Cancer Research | 2010 | 374 |
| 41 | Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer | Breast Cancer Research | 2011 | 365 |
| 42 | The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression | Breast Cancer Research | 2001 | 364 |
| 43 | HER2 therapy: Molecular mechanisms of trastuzumab resistance | Breast Cancer Research | 2006 | 357 |
| 44 | Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways | Breast Cancer Research | 2010 | 354 |
| 45 | The role of bisphosphonates in breast cancer: Development of bisphosphonates | Breast Cancer Research | 2001 | 350 |
| 46 | The microenvironment in breast cancer progression: biology and implications for treatment | Breast Cancer Research | 2011 | 340 |
| 47 | Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients | Breast Cancer Research | 2011 | 327 |
| 48 | Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis! | Breast Cancer Research | 2007 | 325 |
| 49 | E-cadherin expression in primary carcinomas of the breast and its distant metastases | Breast Cancer Research | 2003 | 323 |
| 50 | Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action | Breast Cancer Research | 2004 | 321 |
